Sensorineural Hearing Loss Clinical Trial
Official title:
Efficacy of Digital Noise Reduction Strategies: A Hearing Aid Trial
The purpose of this study is to see if noise reduction programs in digital hearing aids help patients hear better than hearing aids without these programs. We also want to know if we can predict how successful patients will be with hearing aids.
The first goal of this project is to examine the efficacy of digital hearing aids
incorporating three noise reduction strategies (i.e., directional microphones alone vs.
directional microphones with DSP noise reduction algorithm 1 vs. directional microphones
with DSP noise reduction algorithm 2) in terms of both speech understanding outcomes and
functional outcomes. The second goal is to identify individual characteristics that are
predictive of successful functional outcomes with hearing aids.
This study employs a multi-site, randomized, blinded, 2x2 factorial parallel group design.
Three hundred subjects will be studied at three VA Medical Centers (Mountain Home, TN; Bay
Pines, FL; and Los Angeles, CA) over a period of three years.
Objective (word recognition ability and performance with degraded speech stimuli) subjective
(self-assessment questionnaires, personality and depression assessments) and
cost-effectiveness assessments will be measured for 4 randomized treatment groups receiving
different digital hearing aid technology. Subjects will be randomly assigned to wear hearing
aids with directional microphones alone or directional microphones with noise reduction
algorithm 1 or directional microphones with noise reduction algorithm 2 for a period of 8
weeks. Subjects will complete post-testing after 8 weeks of hearing aid use.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00023036 -
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
|
||
Completed |
NCT03746613 -
Clinal Evaluation of Navigation Based Functional Ear Surgery Using Image Guided and Robotically Assisted Techniques
|
N/A | |
Recruiting |
NCT05568329 -
Appreciation for Music Processed by Hearing Aids
|
N/A | |
Withdrawn |
NCT05061758 -
A Trial of LY3056480 in Patients With SNLH
|
Phase 2 | |
Completed |
NCT01434446 -
The Effect of Sound Stimulation on Hearing Ability
|
N/A | |
Completed |
NCT03212924 -
Listening Effort in Cochlear Implant Users
|
N/A | |
Recruiting |
NCT06053190 -
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
|
N/A | |
Completed |
NCT03718975 -
Quality Control of CE-Certified Phonak Hearing Aids - 2018_28
|
N/A | |
Completed |
NCT06025097 -
Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.
|
Early Phase 1 | |
Recruiting |
NCT04102215 -
The Efficacy of a Minimally Invasive Direct Cochlear Access Via the HEARO Procedure
|
N/A | |
Recruiting |
NCT04108598 -
The SeaSHeL National Prospective Cohort Study
|
||
Active, not recruiting |
NCT04750642 -
Cochlear Implant With Dexamethasone Eluting Electrode Array
|
N/A | |
Completed |
NCT04120116 -
FX-322 in Adults With Stable Sensorineural Hearing Loss
|
Phase 2 | |
Recruiting |
NCT06223724 -
Status Telemetry for Cochlear Implantations
|
||
Completed |
NCT02005822 -
Congenital Cytomegalovirus: Efficacy of Antiviral Treatment
|
Phase 3 | |
Suspended |
NCT02616172 -
Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss
|
Phase 1/Phase 2 | |
Completed |
NCT02259595 -
Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC
|
Phase 1 | |
Unknown status |
NCT01902914 -
Effectiveness of P02 Digital Hearing Aids
|
Phase 1/Phase 2 | |
Completed |
NCT00589511 -
Nucleus Freedom Cochlear Implant System Pediatric Post-approval Study
|
N/A | |
Completed |
NCT03288753 -
Comparison Between Neuro 1 and Neuro 2 Cochlear Implant Speech Processors
|
N/A |